Satellos Bioscience Inc. ownership disclosure: three reporting persons state combined beneficial ownership of 1,137,041 ordinary shares, representing 7.35% of the class.
The filing attributes the 7.35% figure to a calculation using 15,458,903 ordinary shares outstanding as of February 5, 2026 and 3,641 common shares issuable upon exercise of options owned by the reporting persons. Ownership breaks down into 126,874 shares with sole voting/dispositive power and 1,010,167 shares with shared voting/dispositive power, held across individuals and affiliated entities named in the filing.
Positive
None.
Negative
None.
Insights
Joint holders disclose a meaningful minority stake and shared control.
Bloom/Burton group reports 1,137,041 shares beneficially owned, or 7.35%, calculated using February 5, 2026 outstanding share data. The position combines directly held shares, options, and shares held by affiliated entities.
The filing shows 1,010,167 shares under shared voting/dispositive power via Bloom Burton entities. Future voting alignments or coordinated actions would depend on the reporting persons' joint control arrangements as described; timing and intent are not stated in the excerpt.
Schedule 13G format and percent calculation are explicitly disclosed.
The disclosure cites the issuer's Rule 424(b)(4) Prospectus for the 15,458,903 shares outstanding denominator and includes 3,641 option shares in the calculation. Ownership details enumerate sole vs shared voting and dispositive powers.
There is no transaction or change-of-control statement; this is a beneficial-ownership filing. Any regulatory or Section 13 obligations would follow from the positions reported and applicable rules, not from additional facts in this excerpt.
Key Figures
Beneficially owned:1,137,041 sharesPercent of class:7.35%Shares outstanding:15,458,903 shares+3 more
6 metrics
Beneficially owned1,137,041 sharesAggregate beneficial ownership reported in Item 4
Percent of class7.35%Ownership percentage stated in Item 4
Shares outstanding15,458,903 sharesOutstanding shares as of <date>February 5, 2026</date> per Rule 424(b)(4) Prospectus
Options issuable3,641 sharesOptions included in denominator for percent calculation
Sole voting power126,874 sharesShares with sole voting/dispositive power reported in Item 4
Shared voting power1,010,167 sharesShares with shared voting/dispositive power held via affiliated entities
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 1,010,167.00"
Rule 424(b)(4) Prospectusregulatory
"15,458,903 ordinary shares outstanding as of February 5, 2026 as reported by the Issuer in their Rule 424(b)(4) Prospectus"
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Satellos Bioscience Inc.
(Name of Issuer)
Common Shares
(Title of Class of Securities)
80401L803
(CUSIP Number)
02/06/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
80401L803
1
Names of Reporting Persons
Brian Matthew Bloom
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
126,874.00
6
Shared Voting Power
1,010,167.00
7
Sole Dispositive Power
126,874.00
8
Shared Dispositive Power
1,137,041.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,133,401.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.35 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) Sole power consists of (i) 67,233 ordinary shares held of record by Brian Matthew Bloom, (ii) 56,000 ordinary shares held of record by 2194655 Ontario Inc., and (iii) options to purchase 3,641 ordinary shares held of record by Brian Matthew Bloom.
(2) Shared power consists of (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc., and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation, which is controlled by Bloom Burton & Co. Inc. Brian Matthew Bloom and Jolyon David Burton jointly control Bloom Burton & Co. Inc. and have the power to direct the voting and disposition of Common Shares held by such entity through their respective ownership interests of such entity.
(3) Row 11(b) is based on the quotient obtained by dividing (a) the aggregate number of ordinary shares beneficially owned by Brian Matthew Bloom as set forth in Row 9 by (b) the sum of (i) 15,458,903 ordinary shares outstanding as of February 5, 2026 as reported by the Issuer in their Rule 424(b)(4) Prospectus, and (ii) 3,641 common shares issuable upon exercise of options beneficially owned by Brian Matthew Bloom.
SCHEDULE 13G
CUSIP Number(s):
80401L803
1
Names of Reporting Persons
Bloom Burton & Co. Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,010,167.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,010,167.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,010,167.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.53 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: (1) Shared power consists of (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc., and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation, which is controlled by Bloom Burton & Co. Inc.
(2) Row 11 is based on the quotient obtained by dividing (a) the aggregate number of ordinary shares beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 15,458,903 ordinary shares outstanding as of February 5, 2026 as reported by the Issuer in their Rule 424(b)(4) Prospectus.
SCHEDULE 13G
CUSIP Number(s):
80401L803
1
Names of Reporting Persons
Jolyon David Burton
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,010,167.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,010,167.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,010,167.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.53 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: (1) Shared power consists of (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc., and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation, which is controlled by Bloom Burton & Co. Inc. Brian Matthew Bloom and Jolyon David Burton jointly control Bloom Burton & Co. Inc. and have the power to direct the voting and disposition of Common Shares held by such entity through their respective ownership interests of such entity.
(2) Row 11 is based on the quotient obtained by dividing (a) the aggregate number of ordinary shares beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 15,458,903 ordinary shares outstanding as of February 5, 2026 as reported by the Issuer in their Rule 424(b)(4) Prospectus.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Satellos Bioscience Inc.
(b)
Address of issuer's principal executive offices:
Royal Bank Plaza, South Tower, 200 Bay Street, Suite 2800, Toronto, Ontario M5J 2J1, Canada
Item 2.
(a)
Name of person filing:
This Schedule 13G is being jointly filed by Brian Matthew Bloom, Bloom Burton & Co. Inc., and Jolyon David Burton, each of the foregoing, a "Reporting Person," and collectively, the "Reporting Persons".
(b)
Address or principal business office or, if none, residence:
181 Bay St., Suite 3410 Toronto, Ontario M5J 2T3, Canada
(c)
Citizenship:
Brian Matthew Bloom and Jolyon David Burton are Canadian citizens. Bloom Burton & Co. Inc. exists under the Business Corporations Act (Ontario).
(d)
Title of class of securities:
Common Shares
(e)
CUSIP Number(s):
80401L803
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
1,137,041,00
Consists of (i) 67,233 ordinary shares held of record by Brian Matthew Bloom, (ii) 56,000 ordinary shares held of record by 2194655 Ontario Inc., and (iii) options to purchase 3,641 ordinary shares held of record by Brian Matthew Bloom as well as (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc. and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation.
(b)
Percent of class:
7.35%
Based on the quotient obtained by dividing (a) the aggregate number of ordinary shares beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 15,458,903 ordinary shares outstanding as of February 5, 2026 as reported by the Issuer in their Rule 424(b)(4) Prospectus and (ii) 3,641 common shares issuable upon exercise of options beneficially owned by the Reporting Person.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
126,874
Consists of (i) 67,233 ordinary shares held of record by Brian Matthew Bloom, (ii) 56,000 ordinary shares held of record by 2194655 Ontario Inc., and (iii) options to purchase 3,641 ordinary shares held of record by Brian Matthew Bloom.
(ii) Shared power to vote or to direct the vote:
1,010,167
Consists of (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc., and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation.
(iii) Sole power to dispose or to direct the disposition of:
126,874
Consists of (i) 67,233 ordinary shares held of record by Brian Matthew Bloom, (ii) 56,000 ordinary shares held of record by 2194655 Ontario Inc., and (iii) options to purchase 3,641 ordinary shares held of record by Brian Matthew Bloom.
(iv) Shared power to dispose or to direct the disposition of:
1,010,167
Consists of (i) 508,334 ordinary shares held of record by Bloom Burton & Co. Inc., and (ii) 501,833 ordinary shares held of record by Bloom Burton Development Corporation.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
They report beneficial ownership of 1,137,041 shares, equal to 7.35% of the class. This percentage uses 15,458,903 shares outstanding as of February 5, 2026 plus 3,641 option shares in the denominator.
Who are the reporting persons in the MSLE filing?
The filing is jointly made by Brian Matthew Bloom, Bloom Burton & Co. Inc., and Jolyon David Burton. The disclosure states shared control and specifies which entities hold record shares and options.
How is voting power allocated in the disclosure?
The group reports 126,874 shares with sole voting power and 1,010,167 shares with shared voting power. The shared amount derives from holdings of affiliated Bloom Burton entities.
Does the filing show any recent purchases or sales of MSLE shares?
No; this Schedule 13G discloses beneficial ownership levels and voting/dispositive powers. The excerpt does not report any specific purchases, sales, or transaction dates.
What role do options play in the reported percentage for MSLE?
Options count 3,641 shares issuable upon exercise and are included in the denominator when calculating the 7.35% ownership percentage per the filing's stated method.
